Jan 30, 2026 by James Halley2 Actually Profitable Pot Stocks To Buy Before Trump's Cannabis ReschedulingRescheduling cannabis to a Schedule 3 drug, if it happens, represents a long-term industry tailwind.
Jan 29, 2026 by James HalleyTrump's Race to Space Superiority: 2 Rocket Stocks Ready to Take Off in 2026And these two space picks are seeing more profits in SaaS models.
Jan 27, 2026 by James HalleyMove Over, Tesla Solar. These 2 Energy Stocks Are Powering The Future of AIVirtual Power Plant providers National Grid and Sunrun are providing solutions to keep up with AI power requirements.
Jan 26, 2026 by James HalleyForget Gold At Over $5,000 Per Ounce: These 2 Precious Metals Plays Are a Much Smarter Move for InvestorsRecord high gold prices will power these two mining behemoths.
Jan 24, 2026 by James Halley2 Under-the-Radar Biotech Stocks Set to Boom in 2026Biotech headwinds are driving double-digit revenue growth and profitability for these two mid-caps.
Oct 31, 2023 by James Halley3 Green Flags and 1 Red Flag for Medical Properties TrustThe beleaguered healthcare REIT has made itself a less risky stock.
Oct 30, 2023 by James Halley5 Reasons Beam Therapeutics Remains a Risky StockShares of the gene-editing biotech might not have hit rock bottom yet.
Oct 28, 2023 by James HalleyRoche, Lilly or Pfizer: Who's the Winner in IBD Wars?The three companies are spending big on IBD therapies.
Oct 27, 2023 by James Halley2 Green Flags and 1 Red Flag for Novartis StockThe Swiss pharmaceutical company just posted strong Q3 numbers and is going through some big changes.
Oct 26, 2023 by James Halley3 Pharma Stocks That Are Screaming Buys in OctoberEach company delivers an above-average dividend and revenue growth.
Oct 25, 2023 by James Halley3 Dental Supply Stocks You Can Sink Your Teeth IntoLong-term trends and margin improvements are driving growth for dental supply companies.
Oct 23, 2023 by James Halley3 Stocks Cathie Wood Is Buying That Should Be on Your List TooThe three companies are positioned to benefit from red-hot trends.
Oct 21, 2023 by James HalleyWhich Is the Better Long-Term Hold for Investors: Pfizer or Roche?The venerable pharmaceutical companies' shares have slumped this year.
Oct 19, 2023 by James Halley3 Things About Bristol Myers Squibb That Smart Investors KnowThe stock is down this year, but will its struggles fade into the rearview mirror?
Oct 19, 2023 by James Halley4 Ways to Grow $100,000 Into $1 Million for RetirementInvesting for big-time growth doesn't have to be risky.
Oct 19, 2023 by James Halley3 Under-the-Radar Biotech Stocks to Buy in 2023These three lesser-known biotech companies are profitable and growing revenue.
Oct 19, 2023 by James HalleyWhich Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy?
Oct 14, 2023 by James Halley2 Robinhood Stocks With Market-Beating PotentialThese diamonds in the rough won't stay down.
Oct 13, 2023 by James HalleyWhy Shares of Revolution Medicines Were Popping on FridayThe company released positive phase 1/1b trial data on two cancer therapies.
Oct 13, 2023 by James HalleyWhy Shares of Harmony Bioscience Are Falling on FridayThe company reported underwhelming phase 3 trial results for Pitolisant to treat idiopathic hypersomnia.
